Cardiac sodium channelopathy associated with SCN5A mutations: Electrophysiological, molecular and genetic aspects

Journal of Physiology

Volumn 591, Issue 17, 2013, Pages 4099-4116

  Remme, Carol Ann ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 2; ANKYRIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALMODULIN; CAVEOLIN 3; DESMOGLEIN 2; FIBROBLAST GROWTH FACTOR 13; FLECAINIDE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE 1 LIKE; MEXILETINE; PLAKOPHILIN 2; PROTEIN 14 3 3; PROTEIN CAMK II D; PROTEIN MOG1; PROTEIN SAP97; PROTEIN TYROSINE PHOSPHATASE H 1; RANOLAZINE; SODIUM CHANNEL NAV1.5; SYNTROPHIN ALPHA 1; TELETHONIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL BETA 1 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BETA 2 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BETA 3 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BETA 4 SUBUNIT; Z BAND ALTERNATIVELY SPLICED PDZ MOTIF PROTEIN; SCN5A PROTEIN, HUMAN;

ACTN2 GENE; AGE; ANK3 GENE; ARTICLE; BRUGADA SYNDROME; CALM GENE; CAMK2D GENE; CARDIAC CHANNELOPATHY; CAV3 GENE; CHANNEL GATING; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DSG2 GENE; ENVIRONMENTAL FACTOR; FGF13 GENE; GENDER; GENE; GENE MUTATION; GENETICS; GPD1L GENE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CONDUCTION DISTURBANCE; HEREDITY; HUMAN; LONG QT SYNDROME 3; MOG1 GENE; MOLECULAR MECHANICS; NEDD4L GENE; NONHUMAN; PHENOTYPE; PKP2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PTPH1 GENE; SAP97 GENE; SCN1B GENE; SCN2B GENE; SCN3B GENE; SCN4B GENE; SCN5A GENE; SICK SINUS SYNDROME; SINUS ARREST; SNTA GENE; SODIUM CHANNELOPATHY; SUDDEN INFANT DEATH SYNDROME; TCAP GENE; TRANSLATION REGULATION; YWHAH GENE; ZASP GENE; ACTION POTENTIAL; ANIMAL; CHANNELOPATHY; LONG QT SYNDROME; METABOLISM; MUTATION; PATHOPHYSIOLOGY;

ACTION POTENTIALS; ANIMALS; BRUGADA SYNDROME; CHANNELOPATHIES; HUMANS; LONG QT SYNDROME; MUTATION; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL;

EID: 84883284224     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.256461     Document Type: Article

References (147)

1. v1.5 and interacting proteins: Physiology and pathophysiology. J Mol Cell Cardiol 48, 2-11.
2. Allouis M, Le Bouffant F, Wilders R, Péroz D, Schott JJ, Noireaud J, Le Marec H, Mérot J, Escande D & Baró I (2006). 14-3-3 is a regulator of the cardiac voltage-gated sodium channel Nav1.5. Circ Res 98, 1538-1546.
3. + channel does not affect ion selectivity properties. Acta Physiol Scand 185, 291-301.
4. Antzelevitch C (2001). The Brugada syndrome: diagnostic criteria and cellular mechanisms. Eur Heart J 22, 356-363.
5. Antzelevitch C (2006). Brugada syndrome. Pacing Clin Electrophysiol 29, 1130-1159.
6. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, Le Marec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H & Wilde A (2005). Brugada syndrome: report of the second consensus conference. Heart Rhythm 2, 429-440.
7. Arnolds DE, Liu F, Fahrenbach JP, Kim GH, Schillinger KJ, Smemo S, McNally EM, Nobrega MA, Patel VV & Moskowitz IP (2012). TBX5 drives Scn5a expression to regulate cardiac conduction system function. J Clin Invest 122, 2509-2518.
8. Ashamalla SM, Navarro D & Ward CA (2001). Gradient of sodium current across the left ventricular wall of adult rat hearts. J Physiol 536, 439-443.
9. V1.5 gating by multiple phosphorylation sites. J Biol Chem 287, 19856-19869.
10. Balser JR (2001). The cardiac sodium channel: gating function and molecular pharmacology. J Mol Cell Cardiol 33, 599-613.
11. Bennett PB, Yazawa K, Makita N & George AL (1995). Molecular mechanism for an inherited cardiac arrhythmia. Nature 376, 683-685.
12. Benson DW, Wang DW, Dyment M, Knilans TK, Fish FA, Strieper MJ, Rhodes TH & George AL Jr (2003). Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 112, 1019-1028.
13. v1.5, a voltage-sensitive sodium channel. J Physiol 588, 4969-4985.
14. Bezzina CR & Remme CA (2008). Dilated cardiomyopathy due to sodium channel dysfunction: what is the connection Circ Arrhythm Electrophysiol 1, 80-82.
15. Bezzina CR, Rook MB, Groenewegen WA, Herfst LJ, van der Wal AC, Lam J, Jongsma HJ, Wilde AAM & Mannens MMAM (2003). Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 92, 159-168.
16. + channel mutation causing both long-QT and Brugada syndromes. Circ Res 85, 1206-1213.
17. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L & Antzelevitch C (2007). Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 116, 1449-1457.
18. Casini S, Tan HL, Bhuiyan ZA, Bezzina CR, Barnett P, Cerbai E, Mugelli A, Wilde AA & Veldkamp MW (2007). Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Cardiovasc Res 76, 418-429.
19. Casini S, Tan HL, Demirayak I, Remme CA, Amin AS, Scicluna BP, Chatyan H, Ruijter JM, Bezzina CR, van Ginneken AC & Veldkamp MW (2010). Tubulin polymerization modifies cardiac sodium channel expression and gating. Cardiovasc Res 85, 691-700.
20. Casini S, Verkerk AO, van Borren MM, van Ginneken AC, Veldkamp MW, de Bakker JM & Tan HL (2009). Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes. Cardiovasc Res 81, 72-81.
21. + channel 'neonatal' splice form. J Neurosci Methods 147, 88-98.
22. Chockalingam P, Rammeloo LA, Postema PG, Hruda J, Clur SA, Blom NA & Wilde AA (2011). Fever-induced life-threatening arrhythmias in children harboring an SCN5A mutation. Pediatrics 127, e239-e244.
23. Chopra SS, Stroud DM, Watanabe H, Bennett JS, Burns CG, Wells KS, Yang T, Zhong TP & Roden DM (2010). Voltage-gated sodium channels are required for heart development in zebrafish. Circ Res 106, 1342-1350.
24. + channels: an original mechanism of arrhythmia. Circulation 107, 2233-2237.
25. Cordeiro JM, Mazza M, Goodrow R, Ulahannan N, Antzelevitch C & Di Diego JM (2008). Functionally distinct sodium channels in ventricular epicardial and endocardial cells contribute to a greater sensitivity of the epicardium to electrical depression. Am J Physiol Heart Circ Physiol 295, H154-H162.
26. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJG, Verkerk AO, de Groot JR, Bhuiyan Z, Bezzina CR, Veldkamp MW, Linnenbank AC, van der Wal AC, Tan HL, Brugada P, Wilde AA & de Bakker JM (2005). Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiologic, genetic, histopathologic and computational study. Circulation 112, 2769-2777.
27. Darbar D, Kannankeril PJ, Donahue BS, Kucera G, Stubblefield T, Haines JL, George AL Jr & Roden DM (2008). Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 117, 1927-1935.
28. Davis RP, Casini S, van den Berg CW, Hoekstra M, Remme CA, Dambrot C, Salvatori D, Oostwaard DW, Wilde AA, Bezzina CR, Verkerk AO, Freund C & Mummery CL (2012). Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 125, 3079-3091.
29. Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, Brugada J, Brugada R & Antzelevitch C (1999). Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 85, 803-809.
30. Ellinor PT, Nam EG, Shea MA, Milan DJ, Ruskin JN & Macrae CA (2008). Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm 5, 99-105.
31. Fredj S, Sampson KJ, Liu H & Kass RS (2006). Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action. Br J Pharmacol 148, 16-24.
32. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F & Russo MA (2005). Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112, 3680-3687.
33. v1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ Res 99, 407-414.
34. Ge J, Sun A, Paajanen V, Wang S, Su C, Yang Z, Li Y, Wang S, Jia J, Wang K, Zou Y, Gao L, Wang K & Fan Z (2008). Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy. Circ Arrhythm Electrophysiol 1, 83-92.
35. George AL Jr (2005). Inherited disorders of voltage-gated sodium channels. J Clin Invest 115, 1990-1999.
36. Gosselin-Badaroudine P, Keller DI, Huang H, Pouliot V, Chatelier A, Osswald S, Brink M & Chahine M (2012). A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype. PLoS One 7, e38331.
37. Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C & Priori S (2002). Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest 110, 1201-1209.
38. Groenewegen WA, Firouzi M, Bezzina CR, Vliex S, van Langen IM, Sandkuijl L, Smits JP, Hulsbeek M, Rook MB, Jongsma HJ & Wilde AA (2003). A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 92, 14-22.
39. + channels. Am J Physiol Heart Circ Physiol 302, H782-H789.
40. Hao X, Zhang Y, Zhang X, Nirmalan M, Davies L, Konstantinou D, Yin F, Dobrzynski H, Wang X, Grace A, Zhang H, Boyett M, Huang CL-H & Lei M (2011). TGF-β1-mediated fibrosis and ion channel remodeling are key mechanisms in producing the sinus node dysfunction associated with SCN5A deficiency and aging. Circ Arrhythm Electrophysiol 4, 397-406.
41. Hoekstra M, Mummery CL, Wilde AA, Bezzina CR & Verkerk AO (2012). Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 3, 346.
42. Hoogendijk MG, Potse M, Linnenbank AC, Verkerk AO, den Ruijter HM, van Amersfoorth SC, Klaver EC, Beekman L, Bezzina CR, Postema PG, Tan HL, Reimer AG, van der Wal AC, Ten Harkel AD, Dalinghaus M, Vinet A, Wilde AA, de Bakker JM & Coronel R (2010). Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch. Heart Rhythm 7, 238-248.
43. Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A, Pfeiffer R, Koopmann TT, Cordeiro JM, Guerchicoff A, Pollevick GD & Antzelevitch C (2009). A mutation in the β3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet 2, 270-278.
44. Ishikawa T, Sato A, Marcou CA, Tester DJ, Ackerman MJ, Crotti L, Schwartz PJ, On YK, Park JE, Nakamura K, Hiraoka M, Nakazawa K, Sakurada H, Arimura T, Makita N & Kimura A (2012). A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. Circ Arrhythm Electrophysiol 5, 1098-1107.
45. +/- hearts: the effects of ageing and sex. Mech Ageing Dev 133, 591-599.
46. v1.5 interacts with and is regulated by the protein tyrosine phosphatase PTPH1. Biochem Biophys Res Commun 348, 1455-1462.
47. v1.5. Biophys J 101, 2147-2156.
48. Kapplinger JD, Tester DJ, Alders M, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicoff A, Harris-Kerr C, Kamakura S, Kyndt F, Koopmann TT, Miyamoto Y, Pfeiffer R, Pollevick GD, Probst V, Zumhagen S, Vatta M, Towbin JA, Shimizu W, Schulze-Bahr E, Antzelevitch C, Salisbury BA, Guicheney P, Wilde AA, Brugada R, Schott JJ & Ackerman MJ (2010). An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 7, 33-46.
49. Kass RS (2006). Sodium channel inactivation in heart: a novel role of the carboxyterminal domain. J Cardiovasc Electrophysiol 17 (Suppl. 1), S21-S25.
50. Kattygnarath D, Maugenre S, Neyroud N, Balse E, Ichai C, Denjoy I, Dilanian G, Martins RP, Fressart V, Berthet M, Schott JJ, Leenhardt A, Probst V, Le Marec H, Hainque B, Coulombe A, Hatem SN & Guicheney P (2011). MOG1: a new susceptibility gene for Brugada syndrome. Circ Cardiovasc Genet 4, 261-268.
51. v1.5 by β1- and β3-subunit co-expression in mammalian cells. Pflugers Arch 449, 403-412.
52. Kolder IC, Tanck MW & Bezzina CR (2012). Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. J Mol Cell Cardiol 52, 620-629.
53. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baró I, Moisan JP, Boisseau P, Schott JJ, Escande D & Le Marec H (2001). Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 104, 3081-3086.
54. Leask A (2007). TGFβ, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 74, 207-212.
55. + channelopathies and sinus node dysfunction. Prog Biophys Mol Biol 98, 171-178.
56. Lemaillet G, Walker B & Lambert S (2003). Identification of a conserved ankyrin-binding motif in the family of sodium channel α subunits. J Biol Chem 278, 27333-27339.
57. Li GR, Lau CP & Shrier A (2002). Heterogeneity of sodium current in atrial vs. epicardial ventricular myocytes of adult guinea pig hearts. J Mol Cell Cardiol 34, 1185-1194.
58. v1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. Biochem Biophys Res Commun 380, 132-137.
59. Li Z, Ai T, Samani K, Xi Y, Tzeng HP, Xie M, Wu S, Ge S, Taylor MD, Dong JW, Cheng J, Ackerman MJ, Kimura A, Sinagra G, Brunelli L, Faulkner G & Vatta M (2010). A ZASP missense mutation, S196L, leads to cytoskeletal and electrical abnormalities in a mouse model of cardiomyopathy. Circ Arrhythm Electrophysiol 3, 646-656.
60. Lin X, Liu N, Lu J, Zhang J, Anumonwo JM, Isom LL, Fishman GI & Delmar M (2011). Subcellular heterogeneity of sodium current properties in adult cardiac ventricular myocytes. Heart Rhythm 8, 1923-1930.
61. 2+ overload and inhibited by ranolazine. J Mol Cell Cardiol 47, 326-334.
62. Liu M, Liu H & Dudley SC Jr (2010). Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ Res 107, 967-974.
63. Lodder EM, Scicluna BP, Milano A, Sun AY, Tang H, Remme CA, Moerland PD, Tanck MW, Pitt GS, Marchuk DA & Bezzina CR (2012). Dissection of a quantitative trait locus for PR interval duration identifies Tnni3k as a novel modulator of cardiac conduction. PLoS Genet 8, e1003113.
64. + current and causes inherited arrhythmias. Circulation 116, 2260-2268.
65. Lopez KN, Decker JA, Friedman RA & Kim JJ (2011). Homozygous mutation in SCN5A associated with atrial quiescence, recalcitrant arrhythmias, and poor capture thresholds. Heart Rhythm 8, 471-473.
66. McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E & Mestroni L (2004). SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110, 2163-2167.
67. McNair WP, Sinagra G, Taylor MR, Di Lenarda A, Ferguson DA, Salcedo EE, Slavov D, Zhu X, Caldwell JH & Mestroni L (2011). Familial Cardiomyopathy Registry Research Group. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol 57, 2160-2168.
68. Makielski JC, Ye B, Valdivia CR, Pagel MD, Pu J, Tester DJ & Ackerman MJ (2003). A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res 93, 821-828.
69. Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y, Ohno S, Nishio Y, Tsuji K, Itoh H, Kimura T, Kita T & Horie M (2008). A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 52, 1326-1334.
70. Malan D, Friedrichs S, Fleischmann BK & Sasse P (2011). Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circ Res 109, 841-847.
71. Malhotra DJ, Chen C, Rivolta I, Abriel H, Malhotra R, Mattei LN, Brosius FC, Kass RS & Isom LL (2001). Characterization of sodium channel α and β-subunits in rat and mouse cardiac myocytes. Circulation 103, 1303-1310.
72. v1.5 function. J Biol Chem 283, 16537-16544.
73. Meadows LS & Isom LL (2005). Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc Res 67, 448-458.
74. Medeiros-Domingo A, Kaku T, Tester DJ, Iturralde-Torres P, Itty A, Ye B, Valdivia C, Ueda K, Canizales-Quinteros S, Tusié-Luna MT, Makielski JC & Ackerman MJ (2007). SCN4B-encoded sodium channel β4 subunit in congenital long-QT syndrome. Circulation 116, 134-142.
75. Meregalli PG, Tan HL, Probst V, Koopmann TT, Tanck MW, Bhuiyan ZA, Sacher F, Kyndt F, Schott JJ, Albuisson J, Mabo P, Bezzina CR, Le Marec H & Wilde AA (2009). Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm 6, 341-348.
76. Meregalli PG, Wilde AA & Tan HL (2005). Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more Cardiovasc Res 67, 367-378.
77. Milstein ML, Musa H, Balbuena DP, Anumonwo JM, Auerbach DS, Furspan PB, Hou L, Hu B, Schumacher SM, Vaidyanathan R, Martens JR & Jalife J (2012). Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia. Proc Natl Acad Sci U S A 109, E2134-E2143.
78. v channel isoforms. Heart Rhythm 8, 1931-1932.
79. v1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A 101, 17533-17538.
80. Montpetit ML, Stocker PJ, Schwetz TA, Harper JM, Norring SA, Schaffer L, North SJ, Jang-Lee J, Gilmartin T, Head SR, Haslam SM, Dell A, Marth JD & Bennett ES (2009). Regulated and aberrant glycosylation modulate cardiac electrical signalling. Proc Natl Acad Sci U S A 106, 16517-16522.
81. Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S & Robinson JL (2008). Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 19, 1289-1293
82. + channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J Gen Physiol 123, 155-165.
83. Murphy LL, Moon-Grady AJ, Cuneo BF, Wakai RT, Yu S, Kunic JD, Benson DW & George AL Jr (2012). Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia. Heart Rhythm 9, 590-597.
84. + channel. Circ Res 80, 370-376.
85. Nguyen TP, Wang DW, Rhodes TH & George AL Jr (2008). Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ Res 102, 364-371.
86. Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y, Smits JF, Flameng W, Clancy CE, Moons L, Vos MA, Dewerchin M, Benndorf K, Collen D, Carmeliet E & Carmeliet P (2001). Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7, 1021-1027.
87. Olesen MS, Holst AG, Svendsen JH, Haunso S & Tfelt-Hansen J (2012). SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation. Heart Rhythm 9, 770-773.
88. Olesen MS, Jespersen T, Nielsen JB, Liang B, Møller DV, Hedley P, Christiansen M, Varró A, Olesen SP, Haunsø S, Schmitt N & Svendsen JH (2011). Mutations in sodium channel β-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res 89, 786-793.
89. Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, Horton SC, Rodeheffer RJ & Anderson JL (2005). Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293, 447-454.
90. Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH & Grace AA (2002). Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A 99, 6210-6215.
91. v1.5 in cardiomyocytes. Circ Res 108, 294-304.
92. Probst V, Kyndt F, Potet F, Trochu JN, Mialet G, Demolombe S, Schott JJ, Baró I, Escande D & Le Marec H (2003). Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. J Am Coll Cardiol 41, 643-652.
93. Probst V, Wilde AAM, Barc J, Sacher F, Babuty D, Mabo P, Mansourati J, Le Scouarnec, S, Kyndt F, Le Caignec C, Guicheney P, Gouas L, Albuisson J, Meregalli PG, Le Marec H, Tan HL & Schott JJ (2009). SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2, 552-557.
94. /+ mice. Heart Rhythm 7, S160.
95. Remme CA & Bezzina CR (2010). Sodium channel (dys)function and cardiac arrhythmias. Cardiovasc Ther 28, 287-294.
96. Remme CA, Scicluna BP, Verkerk AO, Amin AS, van Brunschot S, Beekman L, Deneer VH, Chevalier C, Oyama F, Miyazaki H, Nukina N, Wilders R, Escande D, Houlgatte R, Wilde AA, Tan HL, Veldkamp MW, de Bakker JM & Bezzina CR (2009a). Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ Res 104, 1283-1292.
97. Remme CA, Verkerk AO, Hoogaars WM, Aanhaanen WT, Scicluna BP, Annink C, van den Hoff MJ, Wilde AA, van Veen TA, Veldkamp MW, de Bakker JM, Christoffels VM & Bezzina CR (2009b). The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol 104, 511-522.
98. Remme CA, Verkerk AO, Nuyens D, van Ginneken AC, van Brunschot S, Belterman CN, Wilders R, van Roon MA, Tan HL, Wilde AA, Carmeliet P, de Bakker JM, Veldkamp MW & Bezzina CR (2006). Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 114, 2584-2594.
99. Remme CA & Wilde AA (2013). Late sodium current inhibition in acquired and inherited ventricular (dys)function and arrhythmias. Cardiovasc Drugs Ther 27, 91-101.
100. Remme CA, Wilde AA & Bezzina CR (2008). Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med 18, 78-87.
101. Rivolta I, Abriel H, Tateyama M, Liu H, Memmi M, Vardas P, Napolitano C, Priori SG & Kass RS (2001). Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem 276, 30623-30630.
102. + current density and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res 95, 409-418.
103. v1.5 expression. Cardiovasc Res 93, 12-23.
104. Rossenbacker T, Carroll SJ, Liu H, Kuipéri C, de Ravel TJ, Devriendt K, Carmeliet P, Kass RS & Heidbüchel H (2004). Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Heart Rhythm 1, 610-615.
105. Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC & Donehower RC (1991). Cardiac disturbances during the administration of taxol. J Clin Oncol 9, 1704-1712.
106. Royer A, van Veen TA, Le Bouter S, Marionneau C, Griol-Charhbili V, Léoni AL, Steenman M, van Rijen HV, Demolombe S, Goddard CA, Richer C, Escoubet B, Jarry-Guichard T, Colledge WH, Gros D, de Bakker JM, Grace AA, Escande D & Charpentier F (2005). Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation 111, 1738-1746.
107. Sato PY, Musa H, Coombs W, Guerrero-Serna G, Patino GA, Taffet SM, Isom LL & Delmar M (2009). Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res 105, 523-526.
108. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, Wilde AA, Escande D, Mannens MM & Le Marec H (1999). Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 23, 20-21.
109. Schroder EA, Lefta M, Zhang X, Bartos DC, Feng HZ, Zhao Y, Patwardhan A, Jin JP, Esser KA & Delisle BP (2013). The cardiomyocyte molecular clock, regulation of Scn5a and arrhythmia susceptibility. Am J Physiol Cell Physiol 304, C954-C965.
110. v1.5. J Mol Cell Cardiol 49, 16-24.
111. Schwartz PJ (2006). The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 259, 39-47.
112. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P & Bloise R (2001). Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103, 89-95.
113. Scicluna BP, Tanck MW, Remme CA, Beekman L, Coronel R, Wilde AA & Bezzina CR (2011). Quantitative trait loci for electrocardiographic parameters and arrhythmia in the mouse. J Mol Cell Cardiol 50, 380-389.
114. Shang LL, Pfahnl AE, Sanyal S, Jiao Z, Allen J, Banach K, Fahrenbach J, Weiss D, Taylor WR, Zafari AM & Dudley SC Jr (2007). Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ Res 101, 1146-1154.
115. V1.5 distribution in myocytes via interacting proteins: The multiple pool model. Biochim Biophys Acta 1833, 886-894.
116. Smits JPP, Koopmann TT, Wilders R, Veldkamp MW, Opthof T, Bhuiyan ZA, Mannens MM, Balser JR, Tan HL, Bezzina CR & Wilde AA (2005). A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 38, 969-981.
117. Takehara N, Makita N, Kawabe J, Sato N, Kawamura Y, Kitabatake A & Kikuchi K (2004). A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med 255, 137-142.
118. Tan BH, Valdivia CR, Song C & Makielski JC (2006). Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine. Am J Physiol Heart Circ Physiol 291, H1822-H1828.
119. Tan HL, Bezzina CR, Smits JP, Verkerk AO & Wilde AA (2003). Genetic control of sodium channel function. Cardiovasc Res 57, 961-973.
120. Terrenoire C, Wang K, Tung KW, Chung WK, Pass RH, Lu JT, Jean JC, Omari A, Sampson KJ, Kotton DN, Keller G & Kass RS (2013). Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol 141, 61-72.
121. Tukkie R, Sogaard P, Vleugels J, de Groot I, Wilde AA & Tan HL (2004). Delay in right ventricular activation contributes to Brugada syndrome. Circulation 109, 1272-1277.
122. Ugarte G & Brandan E (2006). Transforming growth factor β (TGF-β) signalling is regulated by electrical activity in skeletal muscle cells. J Biol Chem 281, 18473-18481.
123. Valdivia CR, Medeiros-Domingo A, Ye B, Shen WK, Algiers TJ, Ackerman MJ & Makielski JC (2010). Loss-of-function mutation of the SCN3B-encoded sodium channel β3 subunit associated with a case of idiopathic ventricular fibrillation. Cardiovasc Res 86, 392-400.
124. v1.5 is regulated by Nedd4-2 mediated ubiquitination. Circ Res 95, 284-291.
125. Van den Berg MP, Wilde AAM, Viersma JW, Brouwer J, Haaksma J, van der Hout AH, Stolte-Dijkstra I, Bezzina TCR, Van Langen IM, Beaufort-Krol GC, Cornel JH 2nd & Crijns HJ (2001). Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 12, 630-636.
126. Van den Boogaard M, Wong LY, Tessadori F, Bakker ML, Dreizehnter LK, Wakker V, Bezzina CR, 't Hoen PA, Bakkers J, Barnett P & Christoffels VM (2012). Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J Clin Invest 122, 2519-2530.
127. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, Kamp TJ & Towbin JA (2006). Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114, 2104-2112.
128. + channel. Circ Res 86, e91-e97.
129. Veldkamp MW, Wilders R, Baartscheer A, Zegers JG, Bezzina CR & Wilde AA (2003). Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ Res 92, 976-983.
130. + channels in rabbit ventricular myocytes. Europace 9, 571-577.
131. Viswanathan PC & Balser JR (2004). Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc Med 14, 28-35.
132. Wagner S, Dybkova N, Rasenack EC, Jacobshagen C, Fabritz L, Kirchhof P, Maier SK, Zhang T, Hasenfuss G, Brown JH, Bers DM & Maier LS (2006). Ca/calmodulin-dependent protein kinase II regulates cardiac Na channels. J Clin Invest 116, 3127-3128.
133. + channels and conduction velocity in murine hearts. Circ Res 109, 775-782.
134. Watanabe H, Darbar D, Kaiser DW, Jiramongkolchai K, Chopra S, Donahue BS, Kannankeril PJ & Roden DM (2009). Mutations in sodium channel β1 and β2 subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2, 268-275.
135. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott JJ, Demolombe S, Probst V, Anselme F, Escande D, Wiesfeld AC, Pfeufer A, Kääb S, Wichmann HE, Hasdemir C, Aizawa Y, Wilde AA, Roden DM & Bezzina CR (2008). Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 118, 2260-2268.
136. Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, Wang DW, Hipkens SB, Leake B, Hall L, Kupershmidt S, Chopra N, Magnuson MA, Tanabe N, Knollmann BC, George AL Jr & Roden DM (2011). Striking in vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation 124, 1001-1011.
137. Wedekind H, Smits JP, Schulze-Bahr E, Arnold R, Veldkamp MW, Bajanowski T, Borggrefe M, Brinkmann B, Warnecke I, Funke H, Bhuiyan ZA, Wilde AA, Breithardt G & Haverkamp W (2001). De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 104, 1158-1164.
138. +-channel inactivation. Proc Natl Acad Sci U S A 89, 10910-10914.
139. Wolf CM & Berul CI (2006). Inherited conduction system abnormalities-one group of diseases, many genes. J Cardiovasc Electrophysiol 17, 446-455.
140. Wu G, Ai T, Kim JJ, Mohapatra B, Xi Y, Li Z, Abbasi S, Purevjav E, Samani K, Ackerman MJ, Qi M, Moss AJ, Shimizu W, Towbin JA, Cheng J & Vatta M (2008). α-1-syntrophin mutation and the long QT syndrome: a disease of sodium channel disruption. Circ Arrhythm Electrophysiol 1, 193-201.
141. 1325S mice. Am J Physiol Cell Physiol 301, C577-C586.
142. Yarbrough TL, Lu T, Lee H-C & Shibata EF (2002). Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res 90, 443-449.
143. + channel isoforms at the atrioventricular junction and atrioventricular node in the rat. Circulation 114, 1360-1371.
144. Zareba W, Sattari MN, Rosero S, Couderc JP & Moss AJ (2001). Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the ΔKPQ SCN5A sodium channel gene mutation. Am J Cardiol 88, 1311-1314.
145. Zhang Y, Hartmann HA & Satin J (1999). Glycosylation influences voltage-dependent gating of cardiac and skeletal muscle sodium channels. J Membr Biol 171, 195-207.
146. Zhang T, Yong SL, Drinko JK, Popović ZB, Shryock JC, Belardinelli L & Wang QK (2011). LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice. Int J Cardiol 147, 239-245.
147. v1.5 is modulated by α-actinin-2 interaction. Biochemistry 49, 166-178.